Jialiang Medical (佳量医疗), rebranded in 2026 to Jialiang Brain Science (杭州佳量脑科学股份有限公司, GenLight MedTech), is a Hangzhou-based brain-computer interface and neurosurgery device company founded in 2020. Its data-driven full-stack BCI stack spans the BCmod closed-loop neuromodulation platform, the LaserRO MRI-guided laser ablation system (the first domestically approved brain LITT system, cleared by NMPA in October 2025), in-house BCI chips and AI surgical-planning software, plus the Epilcure closed-loop neurostimulator for drug-resistant epilepsy, with a pipeline covering brain tumors, Parkinson disease and spinal cord injury. The company holds four NMPA Class III registration certificates, 400+ IP filings including 190+ granted patents, cooperates with 50+ top-tier hospitals, and runs dual Hangzhou-Singapore hubs as it pursues FDA and CE registrations.
1
Round
1
Industry
5
Tags
Sep 7, 2026
Latest raise
Funding activity · 1 round
Sep 7, 2026
CNY -1
Series C+
Jialiang Medical Raises Series C+ Jialiang Medical (佳量医疗), rebranded in 2026 to Jialiang Brain Science (杭州佳量脑科学股份有限公司, GenLight MedTech), has raised a Series C…
Read articlePricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
